Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferases - Wikidata - awgldk - TriplyDB

Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferases

Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferases

http://www.wikidata.org/entity/Q24618939

about

Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery USR-VS: a web server for large-scale prospective virtual screening using ultrafast shape recognition techniques Ultrafast shape recognition: method and applications From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2 UFSRAT: Ultra-fast Shape Recognition with Atom Types--the discovery of novel bioactive small molecular scaffolds for FKBP12 and 11βHSD1 Comparison of ultra-fast 2D and 3D ligand and target descriptors for side effect prediction and network analysis in polypharmacology.Shape-based virtual screening with volumetric aligned molecular shapes Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver.Bioinformatics and variability in drug response: a protein structural perspective.Informatics, machine learning and computational medicinal chemistry.Small-molecule ligand docking into comparative models with Rosetta.Prospective virtual screening for novel p53-MDM2 inhibitors using ultrafast shape recognition.CREDO: a structural interactomics database for drug discovery.A Bayesian Target Predictor Method based on Molecular Pairing Energies estimation.A new perspective of shape recognition to discover the phase transition of finite-size clusters.Precursory signatures of protein folding/unfolding: from time series correlation analysis to atomistic mechanisms.Advances in the Development of Shape Similarity Methods and Their Application in Drug Discovery Exploration of Piperidinols as Potential Antitubercular Agents Shape-based similarity searching in chemical databases

P2860

Q26995125-CD6A3C20-3FD9-4867-8D67-123FDE8B48DB Q28275104-94950EF4-3AF0-4563-8351-3F68F087F93F Q28307816-20CD51F9-6CE7-4223-8C05-91D73F3D86A9 Q28538748-ED2E3A19-896B-48B1-AE3E-5C88BCE67F38 Q28543249-75C96428-BA96-4250-9D1F-5B4031C14EE6 Q30486230-D15BF7FD-ADA3-4947-B421-C687C4F0A259 Q34076210-6BC60714-1A23-49C9-A24A-DBA7F548EE82 Q34397745-911462C4-FCE2-4C86-8F20-B32B676083CC Q34468310-73E7108C-A9E8-4E77-8B17-3535B9EB8396 Q35232366-2C7C748C-0A50-41F8-A2FA-9A37726CDFD8 Q36009999-9150B35C-7EB4-4BFF-A993-509377122504 Q37859728-A0E11900-3BE1-49E1-9757-6C9EEBC7B6AD Q38112629-C6B35029-ADEB-49B6-A194-90C1DA4A155D Q39022371-CCA807F4-7182-48DA-B68D-A008AE0AC876 Q42119055-0B1BAEFE-E6B0-406E-B79F-979C349F6790 Q42318149-519A146A-B39A-4BAA-B305-41BA4A1C318D Q47177586-DC6F9168-006A-49D8-A6D9-9312498A8D74 Q51082531-F267F709-CE30-43B0-B5B7-7A2AF6A3995B Q56700832-4268BF03-B6DB-48A8-81CA-9187600CA871 Q57976064-3533959D-B9BA-45D3-999A-A6CF9E1A6918 Q57976067-10B51B8E-7705-46FC-B623-CD0BB22230D1

P2860

Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferases

http://www.wikidata.org/entity/Q24618939

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Prospective virtual screening ...... arylamine N-acetyltransferases

@ast

Prospective virtual screening ...... arylamine N-acetyltransferases

@en

Prospective virtual screening ...... arylamine N-acetyltransferases

@nl

type

label

Prospective virtual screening ...... arylamine N-acetyltransferases

@ast

Prospective virtual screening ...... arylamine N-acetyltransferases

@en

Prospective virtual screening ...... arylamine N-acetyltransferases

@nl

prefLabel

Prospective virtual screening ...... arylamine N-acetyltransferases

@ast

Prospective virtual screening ...... arylamine N-acetyltransferases

@en

Prospective virtual screening ...... arylamine N-acetyltransferases

@nl

P1433

Q24618939-E44AB513-44B7-4CB0-924A-40E01FD5554B

P1476

Q24618939-12F99D55-E3E3-46B1-A395-7397062B870A

P2093

Q24618939-3E8EB6B5-38A8-453D-8B2F-7B3D0A68457F

Q24618939-BE12AE2A-138B-4A43-B93F-AE8253CD8BB3

Q24618939-DFC4A565-C48B-41BF-8D29-486C06F1784B

Q24618939-EE278168-6D48-4A95-BC9E-EE491578D9DB

P2860

Q24618939-16809F6B-2712-4EE2-BF76-8C10A58DC220

Q24618939-2D40BF53-CFE6-4DAB-83E7-4E57FB0D95BC

Q24618939-39124524-2CB7-43B4-97C7-657EA35818B7

Q24618939-3F5E4689-6FF1-4A8C-868D-DA628B8CFF1E

Q24618939-46522BB4-47B7-4042-AD78-8E1AC6E3487A

Q24618939-50F412C7-1D59-480B-B04B-2F233C0DADE4

Q24618939-59763519-E04E-4EE1-B5E3-045D0AB33D84

Q24618939-5B81AF64-C6A7-4C22-8744-BB46789DAE3E

Q24618939-5C21505E-9DB8-4BC9-B544-1022CB9F5ED4

Q24618939-5FE2AE56-429F-4CAA-ADFB-15D6C64882C2

P304

Q24618939-21E6E6E0-A46A-4A8C-BC19-20088EE1EF04

P31

Q24618939-C74F7065-A401-4092-9E05-E05C87E08207

P3181

Q24618939-F2A7BADA-9AB1-42AA-B730-8D0E7E555A3B

P356

Q24618939-534C697A-0DF8-4B2A-92D0-859E2FE4F8F2

P407

Q24618939-EED66E21-0594-40B6-9A3C-56416B7B0276

P433

Q24618939-0E28F387-FEE3-4A92-835C-8AB68360394D

P478

Q24618939-E4514749-95D3-4EF0-A63C-085D3AF99009

P50

Q24618939-7AFE9684-CA57-41D6-9FE9-DBCD9171873F

P577

Q24618939-6B5D0145-B8F1-4360-B13B-22B0962C8871

P5875

Q24618939-5593F83F-5870-4647-9497-747A190D01F4

P698

Q24618939-3ACD8B1F-344E-4B04-92FD-53616E39B7BB

P921

Q24618939-42AEE586-4310-4150-B565-4FE5D1F93B08

Q24618939-62D9DACD-0C52-43F6-8DAF-C3CBA588C3FD

Q24618939-F0CEC572-25F4-4E12-86BF-2FCA64D2AB28

P932

Q24618939-1205C8F5-3128-46D6-B659-C6474193F661

P3181

P356

P1433

Journal of the Royal Society Interface

P1476

Prospective virtual screening ...... arylamine N-acetyltransferases

@en

P2093

Isaac Westwood

http://www.w3.org/2001/XMLSchema#string

Nicola Laurieri

http://www.w3.org/2001/XMLSchema#string

Pedro J Ballester

http://www.w3.org/2001/XMLSchema#string

W Graham Richards

http://www.w3.org/2001/XMLSchema#string

P2860

Distribution of 2-aminofluorene and p-aminobenzoic acid N- acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice

Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases

ZINC--a free database of commercially available compounds for virtual screening

A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction

Reassessment of Ellman's reagent

Virtual screening of chemical libraries.

Moment invariants as shape recognition technique for comparing protein binding sites.

Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver.

The importance of discerning shape in molecular pharmacology.

Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.

P304

335-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2141654

http://www.w3.org/2001/XMLSchema#string

P356

10.1098/RSIF.2009.0170

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26656185

http://www.w3.org/2001/XMLSchema#string

P698

19586957

http://www.w3.org/2001/XMLSchema#string

P921

biomedical engineering

P932

2842611

http://www.w3.org/2001/XMLSchema#string